$0.8500
-0.26-23.42%
Last update: Nov 5, 7:42 PM
Curis Inc (CRIS) Stock Price, Quote, News & History
CRISNASDAQ
Curis gained attention after positive emavusertib data as analyst raised its price target to $43 and highlighted upcoming trial catalysts.
You can purchase shares of Curis (NASDAQ:CRIS) through any online brokerage.
Other companies in Curis’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
Curis has a consensus price target of $305.75.
The stock price for Curis (NASDAQ: CRIS) is $0.7899 last updated November 5, 2026 at 7:42 PM EST.
There are no upcoming dividends for Curis.
Curis does not have any upcoming earnings scheduled.
There is no upcoming split for Curis.
Curis is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas,...
